294 related articles for article (PubMed ID: 31047647)
21. WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype.
Imai K; Nonoyama S; Ochs HD
Curr Opin Allergy Clin Immunol; 2003 Dec; 3(6):427-36. PubMed ID: 14612666
[TBL] [Abstract][Full Text] [Related]
22. Mutations of the Wiskott-Aldrich Syndrome Protein affect protein expression and dictate the clinical phenotypes.
Ochs HD
Immunol Res; 2009; 44(1-3):84-8. PubMed ID: 19082760
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in the biology of WASP and WIP.
Ramesh N; Geha R
Immunol Res; 2009; 44(1-3):99-111. PubMed ID: 19018480
[TBL] [Abstract][Full Text] [Related]
24. The early activation of memory B cells from Wiskott-Aldrich syndrome patients is suppressed by CD19 downregulation.
Bai X; Zhang Y; Huang L; Wang J; Li W; Niu L; Jiang H; Dai R; Zhou L; Zhang Z; Miller H; Song W; Zhao X; Liu C
Blood; 2016 Sep; 128(13):1723-34. PubMed ID: 27330000
[TBL] [Abstract][Full Text] [Related]
25. B-cell intrinsic TLR7 signals promote depletion of the marginal zone in a murine model of Wiskott-Aldrich syndrome.
Kolhatkar NS; Scharping NE; Sullivan JM; Jacobs HM; Schwartz MA; Khim S; Notarangelo LD; Thrasher AJ; Rawlings DJ; Jackson SW
Eur J Immunol; 2015 Oct; 45(10):2773-9. PubMed ID: 26256668
[TBL] [Abstract][Full Text] [Related]
26. Critical requirement for the Wiskott-Aldrich syndrome protein in Th2 effector function.
Morales-Tirado V; Sojka DK; Katzman SD; Lazarski CA; Finkelman FD; Urban JF; Fowell DJ
Blood; 2010 Apr; 115(17):3498-507. PubMed ID: 20032499
[TBL] [Abstract][Full Text] [Related]
27. Autonomous role of Wiskott-Aldrich syndrome platelet deficiency in inducing autoimmunity and inflammation.
Sereni L; Castiello MC; Marangoni F; Anselmo A; di Silvestre D; Motta S; Draghici E; Mantero S; Thrasher AJ; Giliani S; Aiuti A; Mauri P; Notarangelo LD; Bosticardo M; Villa A
J Allergy Clin Immunol; 2018 Oct; 142(4):1272-1284. PubMed ID: 29421274
[TBL] [Abstract][Full Text] [Related]
28. Understanding the molecular basis of Wiskott-Aldrich syndrome.
Abo A
Cell Mol Life Sci; 1998 Oct; 54(10):1145-53. PubMed ID: 9817992
[TBL] [Abstract][Full Text] [Related]
29. Wiskott-Aldrich syndrome protein senses irradiation-induced DNA damage to coordinate the cell-protective Golgi dispersal response in human T and B lymphocytes.
Wen KK; Han SS; Vyas YM
J Allergy Clin Immunol; 2020 Jan; 145(1):324-334. PubMed ID: 31604087
[TBL] [Abstract][Full Text] [Related]
30. Wiskott-Aldrich syndrome protein--dynamic regulation of actin homeostasis: from activation through function and signal termination in T lymphocytes.
Matalon O; Reicher B; Barda-Saad M
Immunol Rev; 2013 Nov; 256(1):10-29. PubMed ID: 24117810
[TBL] [Abstract][Full Text] [Related]
31. Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich syndrome protein (WASp) tyrosine phosphorylation is required for coupling T cell antigen receptor engagement to WASp effector function and T cell activation.
Badour K; Zhang J; Shi F; Leng Y; Collins M; Siminovitch KA
J Exp Med; 2004 Jan; 199(1):99-112. PubMed ID: 14707117
[TBL] [Abstract][Full Text] [Related]
32. Deficiency of Wiskott-Aldrich syndrome protein has opposing effect on the pro-oncogenic pathway activation in nonmalignant versus malignant lymphocytes.
Han SS; Wen KK; Vyas YM
Oncogene; 2021 Jan; 40(2):345-354. PubMed ID: 33139832
[TBL] [Abstract][Full Text] [Related]
33. The chemotactic defect in wiskott-Aldrich syndrome macrophages is due to the reduced persistence of directional protrusions.
Ishihara D; Dovas A; Park H; Isaac BM; Cox D
PLoS One; 2012; 7(1):e30033. PubMed ID: 22279563
[TBL] [Abstract][Full Text] [Related]
34. Nuclear role of WASp in the pathogenesis of dysregulated TH1 immunity in human Wiskott-Aldrich syndrome.
Taylor MD; Sadhukhan S; Kottangada P; Ramgopal A; Sarkar K; D'Silva S; Selvakumar A; Candotti F; Vyas YM
Sci Transl Med; 2010 Jun; 2(37):37ra44. PubMed ID: 20574068
[TBL] [Abstract][Full Text] [Related]
35. Altered BCR and TLR signals promote enhanced positive selection of autoreactive transitional B cells in Wiskott-Aldrich syndrome.
Kolhatkar NS; Brahmandam A; Thouvenel CD; Becker-Herman S; Jacobs HM; Schwartz MA; Allenspach EJ; Khim S; Panigrahi AK; Luning Prak ET; Thrasher AJ; Notarangelo LD; Candotti F; Torgerson TR; Sanz I; Rawlings DJ
J Exp Med; 2015 Sep; 212(10):1663-77. PubMed ID: 26371186
[TBL] [Abstract][Full Text] [Related]
36. Impaired NK-cell migration in WAS/XLT patients: role of Cdc42/WASp pathway in the control of chemokine-induced beta2 integrin high-affinity state.
Stabile H; Carlino C; Mazza C; Giliani S; Morrone S; Notarangelo LD; Notarangelo LD; Santoni A; Gismondi A
Blood; 2010 Apr; 115(14):2818-26. PubMed ID: 20130240
[TBL] [Abstract][Full Text] [Related]
37. The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization.
Snapper SB; Rosen FS
Annu Rev Immunol; 1999; 17():905-29. PubMed ID: 10358777
[TBL] [Abstract][Full Text] [Related]
38. Actin cytoskeletal defects in immunodeficiency.
Moulding DA; Record J; Malinova D; Thrasher AJ
Immunol Rev; 2013 Nov; 256(1):282-99. PubMed ID: 24117828
[TBL] [Abstract][Full Text] [Related]
39. T-cell receptor ligation causes Wiskott-Aldrich syndrome protein degradation and F-actin assembly downregulation.
Watanabe Y; Sasahara Y; Ramesh N; Massaad MJ; Yeng Looi C; Kumaki S; Kure S; Geha RS; Tsuchiya S
J Allergy Clin Immunol; 2013 Sep; 132(3):648-655.e1. PubMed ID: 23684068
[TBL] [Abstract][Full Text] [Related]
40. Impaired dendritic-cell homing in vivo in the absence of Wiskott-Aldrich syndrome protein.
de Noronha S; Hardy S; Sinclair J; Blundell MP; Strid J; Schulz O; Zwirner J; Jones GE; Katz DR; Kinnon C; Thrasher AJ
Blood; 2005 Feb; 105(4):1590-7. PubMed ID: 15494425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
